![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Efficacy of dolutegravir plus lamivudine in treatment-naive people living with HIV without baseline drug-resistance testing: week 24 results of the randomized D2ARLING study
|
|
|
IAS 2023 july 25
E. Cordova1, J. Hernandez Rendon1, V. Mingrone1, P. Martin1, G. Arevalo Calderon1, J. Ballivian1, S. Seleme1, N. Porteiro1 1Fundacion IDEAA, Research Department, Buenos Aires, Argentina
![0726231](../images/072623/072623-3/0726231.gif)
![0726232](../images/072623/072623-3/0726232.gif)
![0726233](../images/072623/072623-3/0726233.gif)
![0726234](../images/072623/072623-3/0726234.gif)
![0726235](../images/072623/072623-3/0726235.gif)
![0726236](../images/072623/072623-3/0726236.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|